[ Price : $8.95]
FDA warns Indias Shimoga Chemicals about CGMP deviations in its production of active pharmaceutical ingredients.[ Price : $8.95]
FDA warns Indias Alembic Research Center that it failed to obtain informed consent for an in vivo bioequivalence study.[ Price : $8.95]
FDA awards Acadia Pharmaceuticals a Fast Track designation for remlifanserin, an investigational, highly selective, 5-HT2A recepto...[ Price : $8.95]
Two InnoDev Partners consultants urge industry to re-embrace the 505(b)(2) approval pathway in instances in which it can save drug...[ Price : $8.95]
China approves more novel oncology drugs than the U.S. between 2020 and 2025, with its annual approval totals surpassing FDAs begi...[ Price : $8.95]
FDA accepts for priority review a Dyne Therapeutics BLA for zeleciment rostudirsen for treating individuals with Duchenne muscular...[ Price : $8.95]
A Nevada businessman enters guilty plea to importing and distributing misbranded prescription erectile dysfunction drugs from Indi...[ Price : $8.95]
A new study published in JAMA Health Forum suggests the market for compounded GLP-1 weight-loss drugs remains robust despite the F...